Advancing Therapies for Patients

Find a clinical trial

Video

page image
shadow image

Text Size

minus image

plus image

plus image

Print

Print image

Email a Friend

Video

Find a clinical trial

CheckMate 067 trial for patients with advanced melanoma

 
 

The results of the CheckMate 067 trial: a phase III trial of nivolumab alone or combined with ipilimumab versus ipilimumab alone in treatment-naïve patients with advanced melanoma

Dr Tobias-Hendrik Arkenau describes the results of the CheckMate 067 trial, a phase III trial of nivolumab alone or combined with ipilimumab versus ipilimumab alone in treatment-naïve patients with advanced melanoma, which showed that nivolumab (NIVO) + ipilimumab (IPI) and NIVO alone had superior clinical activity vs IPI alone. The results with NIVO + IPI and NIVO alone further suggest complementary activity of the two agents. There were no new safety signals or drug-related deaths observed with the combination.

Latest Videos

watch the latest videos.

Learn more

News

news from the industry.

Read more

hero1 image
Sarah Cannon Research UK NHS Ventures
University College London Hospitals
LOC